Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 32

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Conjunctival Inflammation Measured by Confocal Microscopy to Evaluate New Therapeutic Agents

Paul J Gomes; Matt J Chapin; David A Hollander; Mark B Abelson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6708. doi:

ARVO Annual Meeting Abstract July 2019

Quantitation of fibrosis in a rat model of laser-induced CNV

Zsolt Ablonczy; Christopher Schillo; David A Hollander; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1256. doi:

ARVO Annual Meeting Abstract July 2018

A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

Paul J Gomes; Todd Brady; David Hollander; David Clark

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5571. doi:

ARVO Annual Meeting Abstract July 2018

Delay of oscillatory potentials links animal models to diabetes in the human eye

Zsolt Ablonczy; Cristiana Giancarlo; Christopher Schillo; Kortni Violette; Dennis Guberski; Barak Yahalom; Laura Belen; Claire Gelfman; April Hall; David Hollander; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4445. doi:

ARVO Annual Meeting Abstract July 2018

Preclinical Assessment of the Syk Inhibitor PRT2761 for Allergic Conjunctivitis

Andy Whitlock; Laura Belen; Matt J Chapin; Paul J Gomes; Matt Birrell; Anjali Pandey; David Hollander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5568. doi:

ARVO Annual Meeting Abstract July 2018

A Randomized, Double-Masked, Parallel-Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

David Clark; George W Ousler; David Hollander; Todd Brady

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1967. doi:

ARVO Annual Meeting Abstract July 2018

Tablet-Based Reading Tests in Early Dry Age-Related Macular Degeneration

Divya Narayanan; John David Rodriguez; Garrick Wallstrom; Donna L Welch; Keith Jeffrey Lane; Aron Shapiro; David Hollander; Mark B Abelson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2424. doi:

ARVO Annual Meeting Abstract July 2018

Establishing a Colony of Non-human Primates with Cystoid Macular Edema

Laura Belen; Kortni Violette; Christopher Schillo; Christopher Gallotta; Christian Grant; Leslie Jost; David Hollander; Andy Whitlock

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):391. doi:

ARVO Annual Meeting Abstract July 2018

Evaluation of the Durability of Dry Eye Symptom Relief Following Daily Use of TrueTear™

Jeff Penzner; David Hollander; Gail Torkildsen; Stephanie Baba; Mark Holdbrook; Michelle Senchyna

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):914. doi:

ARVO Annual Meeting Abstract June 2017

Use of a Computer-based Critical Flicker Fusion Test Discriminates between Young, Old, and Dry AMD Patients

Connie Slocum; Keith Jeffrey Lane; John David Rodriguez; Aron Shapiro; Mark Abelson; David Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2347. doi:

ARVO Annual Meeting Abstract June 2017

Ocular Allergy and Quality of Life: Patient Survey

Emily Schoemmell; Kara Sicard; Rachel Smith; Yesha Raval; Paul J Gomes; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5757. doi:

ARVO Annual Meeting Abstract June 2017

Blink Location during Reading and its Relationship to Reading Errors and Reading Rate in Normal Subjects

Richard Macleod; Christian Sundstrom; Endri Angjeli; John David Rodriguez; George W Ousler; Keith Jeffrey Lane; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2681. doi:

ARVO Annual Meeting Abstract June 2017

Critical Flicker Fusion Scores Across Stimulus Luminance Ranges in Young and Old

Keith Jeffrey Lane; Christian Sundstrom; Endri Angjeli; Peter Corcoran; John David Rodriguez; Mark B Abelson; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4713. doi:

ARVO Annual Meeting Abstract June 2017

Critical Flicker Fusion Recovery Following Photo-Bleach in Young and Old Subjects

Christian Sundstrom; Endri Angjeli; John David Rodriguez; Peter Corcoran; Keith Jeffrey Lane; Mark B Abelson; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4714. doi:

ARVO Annual Meeting Abstract June 2017

Development and Validation of a Portable Visual Navigation Challenge for Assessment of Retinal Disease in Multi-Centered Clinical Trials

Aron Shapiro; Peter Corcoran; Christian Sundstrom; Endri Angjeli; John David Rodriguez; Mark B Abelson; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3290. doi:

ARVO Annual Meeting Abstract June 2017

Effect of the Intranasal Tear Neurostimulator on Meibomian Glands

Michael Watson; Endri Angjeli; Brian Orrick; Stephanie Baba; Manfred Franke; Mark Holdbrook; George W Ousler; David A Hollander; Michelle Senchyna

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4387. doi:

ARVO Annual Meeting Abstract June 2017

Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye vs Normal Subjects

Peter Corcoran; Michael Watson; George W Ousler; Endri Angjeli; Keith Jeffrey Lane; Mark B Abelson; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):469. doi:

ARVO Annual Meeting Abstract June 2017

Staining, lid hyperkeratinization and blink rate: Differences between DED and MGD

Blaine Brown; Peter Corcoran; George W Ousler; Keith Jeffrey Lane; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2245. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of 0.05% Cyclosporine Ophthalmic Emulsion on Ocular Surface Staining and Visual Function in Subjects Who Experience Discomfort While Engaging in Electronic Visual Tasking

Karl Stonecipher; Gail Torkildsen; Eugene B McLaurin; Linda Villanueva; George W Ousler; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2661. doi:

ARVO Annual Meeting Abstract June 2017

Effect of Activity on Interblink Interval Assessed with Continual Blink Tracking using the iBlink ® System in Normal Subjects

Zhouxiao Wu; Endri Angjeli; John David Rodriguez; George W Ousler; Keith Jeffrey Lane; David A Hollander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2672. doi:

1 2

Next 20 Results »

Advertisement